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Abstract
Background: The hypothesis is that hemoglobin-based metrics are useful tools for estimating malaria endemicity and for
monitoring malaria control strategies. The aim of this study is to compare population hemoglobin mean and anemia
prevalence to established indicators of malaria endemicity, including parasite rates, rates of enlarged spleens in children,
and records of (presumptive) malaria diagnosis among populations living with different levels of malaria transmission.
Methodology/Principal Findings: Convenience sample, multisite cross-sectional household surveys conducted in Papua
New Guinea. Correlations (r
2) between population Hb mean and anemia prevalence and altitude, parasite rate, and spleen
rate were investigated in children ages 2 to 10 years, and in the general population; 21,664 individuals from 156 different
communities were surveyed. Altitude ranged from 5 to 2120 meters. In young children, correlations between altitude and
parasite rate, population Hb mean, anemia prevalence, and spleen rate were high (r
2: 20.77, 0.73, 20.81, and 20.68;
p,0.001). In the general population, correlations between altitude and population Hb mean and anemia prevalence were
0.83 and 0.85, respectively. Among young children, parasite rate correlated highly with anemia prevalence, population Hb
mean, and spleen rate (r
2: 0.81, 20.81, and 0.86; p,0.001). Population Hb mean (corrected for direct altitude effects)
increased with altitude, from 10.5 g/dl at ,500 m to 12.8 g/dl at .1500 m (p,0.001).
Conclusions/Significance: In PNG, where Plasmodium vivax accounts for an important part of all malaria infections,
population hemoglobin mean and anemia prevalence correlate well with altitude, parasite, and spleen rates. Hb
measurement is simple and affordable, and may be a useful new tool, alone or in association with other metrics, for
estimating malaria endemicity and monitoring effectiveness of malaria control programs. Further prospective studies in
areas with different malaria epidemiology and different factors contributing to the burden of anemia are warranted to
investigate the usefulness of Hb metrics in monitoring malaria transmission intensity.
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Introduction
Malaria, with about 500 million cases reported per year
worldwide, remains one of the predominant diseases in tropical
countries. The intensity of malaria transmission depends on a
variety of factors such as climate and geographical context, human
population, socio-economical level and vector ecology, as well as the
type of control strategies in place. Nowadays, several efficient
strategies are being used to decrease the malaria burden. Most
prominent among them are insecticide treated bed nets (ITN),
indoorsresidual spraying(IRS),artemisinincombinationtreatments
(ACT)[1,2,3] and intermittent preventive treatment strategies in
pregnant women or infants[4]. Adequately and simply measuring
malaria endemicity is thus of prime importance in order to plan and
monitor effectiveness of these control interventions.
Different tools and metrics have been used for more than 150
years to investigate the level of malaria endemicity in a given
population. Traditionally, the spleen rate (SR), i.e. the prevalence
of splenomegaly in a population, has been used to classify malarial
endemicity[5]. This measure however suffers from a lack of
specificity. Indeed, many diseases highly prevalent in the tropics
may also lead to splenomegaly like visceral leishmaniasis or
schistosomiasis. More importantly, it has been shown in Papua
New Guinea (PNG) by Brabin et al. that the spleen rate may vary
between sub-populations of non-pregnant women with similar
levels of exposure to malaria[6], probably due to differences in
immune response to malaria. Splenomegaly can also be difficult to
measure reproducibly.
In the 1950’s, the prevalence of blood stage malaria parasites
(parasite rate for all species, PR) was introduced as the principal
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method of choice[7]. This metric is much more specific but tends
to be influenced by seasonal fluctuations and is strongly age-
dependent. In addition, it requires blood collection and expert
microscopy that may not be available in resource-limited settings.
Utilizing both SR and PR in children 2–10 years, a classification of
malaria endemicity was proposed by WHO and revised by
Metselaar et al[7]: hypoendemic if SR 2–10 or PR 2–10 is ,10%,
mesoendemic if SR 2–10 or PR 2–10 is 10–50%, hyperendemic if
SR 2–10 or PR 2–10 is 51–75% and holoendemic if SR 2–10 or
PR in children ,1year is .75%. These measures may provide
good estimates of malaria endemicity in areas where malaria is
highly prevalent, but they are less accurate when malaria
transmission is lower[8] such as in an aggressive control program.
The Annual Parasite Incidence (API=number of malaria cases/
population, usually expressed per 1000, a malaria episode is
confirmed by a positive blood slide) is thus often used in areas of
lower transmission. However, this metric requires even more
resources than measuring PR including a reliable reporting system
for malarial episodes.
All these different metrics have been integrated into control
strategies such as the Global Malaria Eradication Programme
coordinated by the World Health Organization (WHO) since the
mid 1950’s. More recently the Malaria Atlas Project (www.map.
ox.ac.uk), used the Plasmodium falciparum (Pf) parasite Rate (PfPR),
usually in children 2–10 years[9], and Pf Annual Parasite
Incidence (PfAPI) to map Pf endemicity. As part of this work,
Hay and colleagues published an extensive and detailed review on
the tools and strategies available to monitor malaria endemicity
[10].
Given the limitations of the traditionally used measures of
malaria endemicity outlined above, there is therefore a need to
identify additional easily implementable tools for the accurate
measurement of malaria endemicity in a variety of transmission
settings.
It is well known that one of the main clinical features of malaria
at an individual level is a fall in hemoglobin (Hb), often resulting in
anemia [11,12,13]. However, little is known of how Hb varies at a
population level relative to changes in malaria transmission
intensity. Two studies have shown associations between altitude
variations and changes in malaria prevalence, with Pf prevalence
decreasing with altitude[14,15]. In the same studies, Hb
concentrations of individuals were also found to increase with
altitude. This suggests that both the population hemoglobin mean
(popHb) and anemia prevalence (AP), following correction for
altitude, correlate directly with the variations of malaria
transmission intensity and may thus be useful as measures of
malaria endemicity. However, the evidence for this direct
correlation is lacking as the existing data are limited by the
sample size or the number of locations. Furthermore, all studies
have been performed in Africa where Pf is the predominant
species. Therefore, there is a need to investigate the association
between Hb measurements at a population level and malaria in
larger datasets from areas with a wider range of altitude, malaria
prevalence and plasmodium species.
PNG is situated in the South-West Pacific and presents a wide
range of malaria endemicity due to its mountainous geography,
ranging from highly prevalent at sea level to absent in the
highlands (up to 4000 meters)[16]. Another characteristic of PNG
is that all four species of plasmodium are present, with Plasmodium
falciparum (Pf) responsible for more than 50% of all clinical malaria
episodes, and Plasmodium vivax (Pv) being responsible for most of
the remaining cases. In past surveys, entomological inoculation
rate (EIR) has varied between ,1 and 400[16]. Overall, malaria is
the main cause of hospital admissions in lowland areas, but is
absent in much of the highlands. Thus, PNG is an ideal site to
investigate the relationship and correlation between classical
measures of malaria transmission intensity, altitude and variations
of population Hb levels and anemia prevalence.
Methods
Study Site and Patients
Individual informed consent was obtained from all participants
or in case of children their guardians before enrolment into the
study. Malaria surveys conducted in the Highlands of PNG
[17,18,19,20] were performed on behalf of the PNG National
Department of Health and the consent was verbal. In the lowlands
surveys that were parts of research studies, written consent was
obtained. All participants specifically consented for a finger prick
blood sample to be collected and assessed for the presence of
malaria and anaemia. This Consent process was approved by the
PNG Medical Research Advisory Council of Papua New Guinea
(respective approval numbers are: Highlands: 00.26, Sepik: 05.08
and Madang: 05.20)
The study was performed in PNG alongside a series of
household malaria surveys performed in three different regions
of the country: the Highlands (inland, 500–2100 m), the Middle
Sepik (lowland, ,500 m) and Madang (coastal, ,500 m). The
different villages were chosen according to their location and
representativeness in terms of presumptive malaria endemicity and
population diversity. Further details of the selection of Highlands
and Sepik survey locations and of the survey methodology are
given by Mueller et al. (2003–2009) [17,18,19,20,21,22,23,24]. In
short, within each village a household based survey was conducted
using convenience sampling. All members of a participating
household were enrolled in the surveys after individual consent.
Medical history of malaria (history of fever, treatment for malaria
and other spontaneously reported symptoms) and a brief medical
examination including spleen measurement (using Hackett’s
classification), axillary temperature and targeted clinical examina-
tion were performed. All patients presenting with signs or
symptoms of malaria had a rapid diagnostic test performed, and
malaria treatment was provided if positive. A finger prick was
performed on each participant, blood slides with thick and thin
films for malaria microscopy were made and Hb was measured
using a portable Hemocue 201H machine (Angelholm, Sweden) in
g/dl. The Madang surveys were conducted in the context of
preparatory works for a trial of intermittent preventive treatment
in infants (IPTi), using the same methodology. Surveys conducted
in villages with epidemic outbreaks of malaria were not used for
this study.
All blood smears were stained with 2.5% buffered Giemsa
(pH 7.2) for 35 minutes and examined by light microscopy. Slides
were declared negative if no parasites were seen in 100 thick film
fields by two different microscopists. The parasite species in
positive films were identified and densities were recorded as the
number of parasites/200 WBC. Densities were calculated
assuming 8,000 WBC/ml [25]. All slides with densities less than
200 /ml, along with a randomly selected 20% of all blood films
were routinely re-examined. If less than 80% concordance was
achieved between evaluations, the entire batch of slides was re-
read.
There is no standardized cut-off value for defining anemia for
individuals [26] in tropical countries. In order to calculate the
prevalence of anemia (AP) for each community, we defined a cut-
off value of 11 g/dl which is clinically meaningful, easy to interpret
from a public health perspective and gives a good proxy to anemia
Malaria Endemicity and Anemia
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hemoglobin mean values (popHb) were calculated for all
communities. Adjustment was done for sex, age and altitude.
Sex and age were adjusted using non-parametric regression
splines. Hb was adjusted for altitude using the model published by
the CDC [27,28,29] with the following formula calculating the
correcting factor for the different Hb values: DHb [g/L]=20.32 x
(altitude[m] x 0.0033)+0.22 x (altitude[m] x 0.0033)
2.
All metrics (popHb, AP, SR and PR) were calculated for both
the general population and children 2–10 years. Indeed, spleen
rate and parasite rate are usually calculated in this age group for
defining malaria endemicity categories[7].
Statistical Methods
All data were analyzed using STATA software, version 10.0.
Correlations between the different metrics and altitude were
investigated by calculating Pearson’s correlation coefficients (r
2);
significance was assessed by calculating p-values. The same
software was used to draw a graph of the correlations between
the different metrics weighted for the number of individuals per
village. We performed also an ANOVA analysis to investigate the
variation of the different metrics across altitude strata. As both Hb
metrics and prevalence of infection are subject to measurement
and sampling errors, major axis regression [30] was used to
determine the symmetric relationship between Hb metrics and
prevalence of infection in children 2–10 yrs. The resulting
relationships are bi-directional, i.e. prevalence of infection can
be predicted from Hb metrics and vice versa All analyses were
done on data aggregated at the village/population level and did
not include measures of individual level variation.
Results
21,664 individuals from 156 different communities were
surveyed from the Highlands, Madang and Sepik areas, altitudes
ranged from 5 to 2120m above sea level. On average there were
143 participants in a village (range [35–387]). Overall, the median
for age was 14.9 years (range [0–99]) with 51.4% of participants
female. Among the villages, 27 were at elevations below 500 m, 17
were between 500 and 999 m, 55 were between 1000 and 1499 m
and 57 were above 1500 m altitude. The ratio of Pf/Pv prevalence
rates among the 145 villages is 2.04 (range [0–17]).
The PR in 2–10 (F3, 148=75.6, p,0.001) and SR 2–10
(F3,147=47.0, p,0.001) were found to decrease significantly from
58.1% and 37.8% in villages ,500 m to 4.3% and 1.6% in those
.1500 m. AP also decreased significantly with altitude (,500 m:
62.8%, .1500 m: 12.3%, F3,143=114.0, p,0.001) while PopHb
increased (altitude adjusted: ,500 m 10.5 g/dl, .1500 m 12.8 g/
dl, F3,148=74.3, p,0.001). Complete altitude stratification data
are shown in Table 1.
Overall, very high correlations were observed between altitude
and the different metrics for malaria endemicity, as shown in
Table 2, both in the general population: PR=20.80, SR=20.60,
crude popHb=0.83 and AP=20.85 and in children 2–10 years:
PR 2–10=20.77, SR 2–10=20.68, crude popHb 2–10=0.73
and AP 2–10=20.81 (all correlations: n=156, p,0.001).
Similarly high correlations were found between PR (overall and
in children 2–10) and other metrics (Table 2, p,0.001). Plots of
individual measures however do reveal differences between the
different measures (Figure 1). PopHb and AR decrease linearly at
altitudes above 500 m but do vary less at lower altitudes, while at
altitude .1500 m rates of enlarged spleens were very low.
Accordingly, the strength of the association between the different
metrics varied across altitudinal strata (Table 3). The correlations
between Hb metrics (popHb and AP) and PR 2–10 were strongest
between 1000–1499 m altitude, and disappeared above 1500 m:
r
2,500 m: 20.42 & 0.48, 500–999 m: 20.53 & 0.43, 1000–
1499 m: 20.62 & 0.68 and .=1500 m: 20.14 & 0.2.
Using major axis regression, the following relationships were
found to best describe the (linear) relationship between Hb metrics
and the prevalence of infections in children 2 to 10 years and
Hb metrics: P2to10=0.854 * AP – 0.162 and P2to10=20.204 *
PopHB +2.73.
Discussion
Using a very large data set from Papua New Guinea, this study
has investigated the correlation between altitude, commonly used
metrics (spleen rate and parasite rate in children 2–10 years and
records of febrile illnesses) and hemoglobin levels expressed as
population mean hemoglobin (PopHb) and prevalence of anemia
(AP) per community. As shown in earlier studies in Tanzania and
Kenya [14,15], in PNG PR and SR were strongly correlated with
altitude indicating that altitude is a reasonable proxy for malaria
endemicity in PNG. In the present study, it was observed that both
PopHb and AP were also strongly associated with altitude
variations. Crude measures of Hb performed as well as those that
were adjusted for effects of age, gender and altitude. Hb
measurements were also closely correlated with PR and SR.
In an altitude-stratified analysis, a progressive increase of
PopHb is observed, from 10.5 g/dl on average below 500 m, to
12.8 g/dl above 1500 m, after correction for altitude. Of factors
Table 1. Metrics for village malaria endemicity by altitude.
Altitude ,500 m
500–
999 m
1000–
1499 m .1500 m
n=27 n=17 n=55 n=57 p
Mean CI95% range Mean CI95% range Mean CI95% range Mean CI95% range
PopHb (crude) 10.5 10.4–10.7 9.0–11.3 11.2 10.9–11.6 10.0–12.9 12.4 12.2–12.6 10.5–14.4 13.3 13.1–13.4 11.7–14.7 ,0.001
PopHb Adj* 10.5 10.4–10.7 9.0–11.3 11.2 10.8–11.5 10.0–12.8 12.2 11.9–12.4 10.2–14.1 12.8 10.4–10.7 11.4–14.2 ,0.001
AP 0.63 0.60–0.66 0.52–0.82 0.46 0.39–0.53 0.17–0.68 0.25 0.21–0.29 0.01–0.58 0.12 0.1–0.14 0–0.35 ,0.001
SR 2–10 0.38 0.31–0.44 0–0.6 0.36 0.23–0.49 0–0.75 0.12 0.08–0.16 0–0.68 0.02 0.01–0.02 0–0.14 ,0.001
PR 2–10 0.58 0.51–0.65 0.1–0.92 0.41 0.30–0.51 0.05–0.69 0.2 0.15–0.25 0.0–0.68 0.04 0.03–0.06 0.0–0.21 ,0.001
*adjusted for altitude.
AP=anemia prevalence, SR 2–10=spleen rate in children 2 to 10 years and PR 2–10=parasite rate in children 2 to 10 years.
doi:10.1371/journal.pone.0009375.t001
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PLoS ONE | www.plosone.org 3 February 2010 | Volume 5 | Issue 2 | e9375Figure 1. Scatter plots of correlations with altitude and Parasite Rate 2–10 years for different metrics. The different metrics are:
Population hemoglobin mean (PopHb), Anemia Prevalence (AP), both in general population and 2–10 years and Spleen Rate in 2–10 years (SR 2–10).
Each circle represents one village.
doi:10.1371/journal.pone.0009375.g001
Table 2. Summary of Pearson’s coefficients of correlation (r
2) between altitude (Alti), population haemoglobin mean (PopHb)
crude or adjusted (for age, sex and altitude), anaemia prevalence (AP), parasite rate (PR) and spleen rate (SR) in the general
population (Pop) and children 2–10 years, in non-epidemic context*.
Crude PopHb
(pop)
Crude PopHb
(2–10 y)
Adjusted
PopHb
AP
(pop)
AP
(2–10 y)
PR
(pop)
PR
(2–10 y)
SR
(pop)
SR
(2–10 y)
Alti 0.83 0.73 0.78 20.85 20.81 20.8 20.77 20.6 20.68
Crude PopHb Pop 0.94 0.99 20.98 20.95 20.79 20.81 20.67 20.75
2–10 years 0.95 20.93 20.95 20.7 20.77 20.65 20.75
Adjusted PopHb Pop 20.97 20.94 20.77 20.79 20.65 20.74
AP Pop 0.96 0.79 0.81 0.67 0.76
2–10 years 0.75 0.79 0.65 0.74
PR Pop 0.96 0.71 0.82
2–10 years 0.76 0.86
SR Pop 0.93
2–10 years
*All coeficients have a p,0.001.
AP=anemia prevalence, SR=spleen rate and PR=parasite rate.
doi:10.1371/journal.pone.0009375.t002
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malaria is likely to be the most important one. Other ‘‘prevalence’’
metrics (AP, SR 2–10 and PR 2–10) all show progressive decreases
with increasing altitude. Correlation of Hb metrics and PR 2–10
are stronger at altitude between 500 and 1500 m, where
endemicity is higher (see Figure 1 and Table 3).
By nature, single cross-sectional surveys are not well suited to
describe malaria endemicity in areas of significant seasonality.
Although Hb level also show some seasonal variations [31], they
are more strongly associated with the history of parasitaemia
preceding the Hb measurement than with concurrent parasite
densities [32]. Mean Hb levels thus are a measure of mean
exposure in the preceding 3 months rather than representing a
single time point like parasite prevalence rate. Nevertheless, when
comparing Hb metrics between areas or over the time of an
antimalarial intervention, it is important to either conduct surveys
during the same period of the year or to adjust for seasonal
variations in the relationship between malaria and Hb levels.
Throughout PNG P. falciparum, P. vivax, P. malariae and P. ovale
are co-endemic. In most areas P. falciparum is the most common
infection followed by P. vivax and in particular in highly endemic
areas mixed species infection are very common [24,33]. While
infections with any species can result in anemia, P. falciparum
infection tend to be associated with a stronger reduction in Hb
levels [21,22,23] and the higher risk of severe anemia [34,35] than
P. vivax. However, as prevalence of infection with all species
increases in parallel with increasing endemicity, it is difficult to
attribute parts of the observed effect of malaria on Hb levels to
individual species. Consequently, overall prevalence rates show
stronger association with Hb metrics than either P. falciparum or P.
vivax specific prevalence rates (data not shown). Finally, it is likely
that increasing drug resistance to malaria infections will not have
the same effect on the different metrics. A recent study in the
Gambia showed higher rates of severe anemia in children infected
with chloroquine resistant P. falciparum [36]. Similarly, the high
rates of severe anemia observed in both hospitalized P. falciparum
and P. vivax patients in Indonesian Papua was linked to the very
high rate of drug resistance [37]. It is thus possible that that an
increase in drug resistance might change the pattern of clinical
malaria episodes and that consequently Hb levels might be
affected differently from PR.
Besides malarial infections there are a number of different
factors that also impact on Hb levels. Of these, it is straightforward
to control for altitude, sex and age. As shown in this study, such
adjustment may however not necessarily improve the strength of
the association between Hb and malarial endemicity.
Other important contributors to the burden of anemia include
infections, nutrition status and host genetic traits such as common
red blood cell polymorphisms. Among infections, hookworm
infestation is probably the most important in PNG. It is highly
prevalent throughout the country [38,39]. Although high egg loads
may be associated with anemia in some populations of PNG[40],
other studies did not find such a link [38]. Adjusting for the
presence of helminth infections would thus potentially improve the
accuracy of Hb metric. Unfortunately these data are not available
for the PNG surveys. Given the nation-wide presence of
hookworm and the lack of consensus on its impact on Hb levels
in PNG it is however unlikely that this would have substantially
changes the observed relationships between Hb and malaria at the
population level. Parvovirus B19 infection has recently been
identified as a significant risk factor for severe anemia in PNG[34],
but as an infection of young children with limited variation
between populations[41] the effect of B19 infection will mainly
affect this age group and to a lesser extent the adult population.
To-date, no studies have investigated the overall contribution of
B19 infections to the burden of anemia. Schistosomiasis, which
contributes a lot to the burden of anemia elsewhere, is not present
in PNG. In other malaria endemic areas like Africa, it will
however be necessary to take into account other infectious agent.
In particular, Schistosomiasis as an important confounder and
adjustment might thus be required where it is endemic. In
conclusion, whereas co-infections might potentially affect popula-
tion Hb levels, the actual impact will depend on epidemiological
context and due to the lack of appropriate co-infection data is
often difficult to quantify.
Secondly, dietary factors such as malnutrition or micronutrient
deficiencies impact on Hb levels. A recent review by Metz has
shown that folate and vitamin B12 deficiency, even though very
frequent in developing countries, do not significantly affect the
prevalence of anemia[42]. Vitamin A (by affecting erythropoie-
sis[43]) and Iron deficiencies are the two micronutrients which are
contributing the most to anemia. Low levels of Vitamin A may also
contribute to an increase risk of malaria [44]. In the 2005 PNG
National Malnutrition survey 15% of children ,5 years had low
levels of VitA with little regional difference. VitA deficiency was
however almost completely absent in adults (Saweri, pers.
communication). In the same survey 23% of people had elevated
transferrin receptor (TfR) levels that were indicative of iron
Table 3. Correlations between different measures of malaria endemicity by altitudinal strata. AP=anemia prevalence and PR 2–
10=parasite rate in children 2 to 10 years.
Altitude ,500 m
500–
999 m
1000–
1499 m .=1500 m
n=154 n=147 n=151 n=152
HbPop AR SR 2–10 HbPop AR SR 2–10 HbPop AR SR 2–10 HbPop AR SR 2–10
PR 2–10 20.42** 0.48** 0.83* 20.53** 0.43*** 0.55** 20.62* 0.68* 0.32* 20.14*** 0.2*** 0.32**
HbPop 20.93* 20.29*** 20.96* 20.52** 20.96* 20.6* 20.9* 20.19***
AR 0.52** 0.62* 0.65* 0.18***
*p,0.01,
**p,0.05,
***p.0.05.
doi:10.1371/journal.pone.0009375.t003
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significant with age and among regions, the prevalence of elevated
TfR among anemic participants (defined as ,10 g/dl for children
,11 for adults) was similar in children and adults (42–47%), albeit
lower in highlands (19–32%) compared to lowlands population
(38–64%). While chronic protein energy malnutrition and
resulting growth stunting is highly prevalent throughout PNG
[45], acute malnutrition is less common overall but more
important in the coastal areas than in the highlands [46]. The
relationship between protein-energy malnutrition, malaria and
anemia is complex and not fully understood. Some recently
published data suggest that malnutrition contributes to both
malaria associated morbidity and anemia [47,48,49] while an
earlier study in lowlands PNG found a reduced risk of malaria in
stunted children [50]. However, in studies in highly endemic areas
where both have been assessed malaria is usually a much stronger
contributor to anemia than malnutrition[51]. Whereas adjusting
for nutritional status might thus improve the accuracy and
predictive value of Hb metrics, such data is rarely collected in
malariological surveys.
Finally, there are a number of genetic traits that are known to
impact on hemoglobin levels. By far the most important one in
PNG is alpha-thalassemia 2 (-a) which is very common in lowlands
PNG but virtually absent in highlands populations[52]. This form
of alpha-thalassemia only causes mild symptoms and even in its
homozygote presentation, it has only a minor effect on
hemoglobin levels[53]. The homozygote however has a significant
protection against severe malaria (including severe malarial
anaemia) and severe non-malarial illnesses[54]. Thus, a potential
negative effect of alpha-thalassaemia on population Hb may be
off-set by a reduction in risk of malaria associated (severe) anemia.
Its overall impact on popHb and AR is likely to be limited. The
other two common red blood cell polymorphisms are South East
Asia Ovalocytosis[55] and the Gerbich blood group[56]. Although
both traits are restricted to malaria endemic areas[57], they both
cause little or no difference in Hb levels[58]. Sickle cell anemia is
not present in PNG. Consequently, the impact of host genetic
polymorphisms on the association between Hb levels or anemia
prevalence and malaria exposure is likely to be minor in PNG.
Importantly, changes in malaria transmission intensity will occur
much more rapidly than those in frequency of host genetic
polymorphisms. Thus, even if such traits may affect Hb levels,
changes in popHb or AR over time would still correctly reflect
changes in malaria endemicity.
After consideration of these important potential confounders,
the correlations between Hb metrics and altitude, parasite
prevalence and spleen rates appear to remain robust. This study
therefore provides good evidence that popHb and AP are valuable
metrics to estimate the burden of malaria in PNG even without
adjusting for potential confounders. Before applying them to other
settings, in particular those where schistosomiasis is highly
prevalent, it will be important to cautiously consider the impact
of such confounders when interpreting Hb levels as malaria metics.
The major advantages of using Hb metrics as measures for
malaria endemicity is that they require limited resources to be
recorded, they are immediately available in the field and are more
reproducible than estimating spleen rate. In addition, popHb is
very easy to calculate and AP easy to interpret. Last but not least
they also provide important additional information on the health
status of a population.
Hb metrics thus appear to be promising alternative tools for
measuring malaria burden, on their own or in combination with
other traditional or more recent serological[59] measures of
malaria endemicity, even in areas of high prevalence of non-
falciparum infections. They may be particularly useful in areas of
moderate to low transmission and could therefore be of best use in
public health when monitoring malaria control interventions
programs during the preparatory and attack phases[10]. Addi-
tional in-depth studies are warranted to better characterize the
relationship between Hb levels and malaria transmission and
determine the optimal use as new malaria metrics. In addition,
prospective studies in areas with different malaria epidemiology
and in the context of malarial control initiatives are required. The
examination of changes in Hb-based indices over time in
populations benefitting from a major anti-malaria intervention
would comprise an important test of the usefulness of Hb metrics
based endemicity monitoring in the context of rapidly changing
malarial epidemiology in Papua New Guinea or elsewhere.
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